The Food Production Environment and the Development of Antimicrobial Resistance in Human Pathogens of Animal Origin
Open accessThe DOI matches its Crossref record; 121 of the 122 references it cites were found in a registry or an index; none of the 37 sources its claims cite is checked for support yet.
Abstract
Food-borne pathogens are a serious human health concern worldwide, and the emergence of antibiotic-resistant food pathogens has further confounded this problem. Once-highly-efficacious antibiotics are gradually becoming ineffective against many important pathogens, resulting in severe treatment crises. Among several reasons for the development and spread of antimicrobial resistance, their overuse in animal food production systems for purposes other than treatment of infections is prominent. Many pathogens of animals are zoonotic, and therefore any development of resistance in pathogens associated with food animals can spread to humans through the food chain. Human infections by antibiotic-resistant pathogens such as Campylobacter spp., Salmonella spp., Escherichia coli and Staphylococcus aureus are increasing. Considering the human health risk due to emerging antibiotic resistance in food animal–associated bacteria, many countries have banned the use of antibiotic growth promoters and the application in animals of antibiotics critically important in human medicine. Concerted global efforts are necessary to minimize the use of antimicrobials in food animals in order to control the development of antibiotic resistance in these systems and their spread to humans via food and water.
Overview
CoChat Summary
## TL;DR
This paper argues that antimicrobial use in food animals, especially non-therapeutic uses such as growth promotion and prophylaxis, is a major driver of antimicrobial resistance that can spread to humans through the food chain, environment, and farm contact. It supports this with examples and surveillance data showing resistance increases after use of specific drugs and decreases after bans or restrictions.
## Key findings
- The paper states that, globally, 63,200 tons of antibiotics were used in livestock in 2010, and this is estimated to rise by 67% to 105,600 tons by 2030.
- In the United States, an estimate from 2012 found that 72.5% of 12,272 tons of medically important antibiotics were used in animals and 27.5% in humans; it also says nearly 80% of antibiotics produced in the U.S. are used in animal husbandry.
- It reports that food animals and workers on farms using AGPs harbor more antibiotic-resistant bacteria than those from farms not using AGPs, and a U.S. study found poultry workers had a 32-times-higher risk of carrying gentamicin-resistant E. coli than community referents.
- Specific examples link use and resistance: avoparcin in chicks led to vancomycin-resistant Enterococcus faecium (VRE), and banning avoparcin in the European Union in 1997 decreased VRE in poultry and the community; reduced tylosin use in 1998–1999 was followed by decreased erythromycin resistance in E. faecium and E. faecalis from pigs.
## Methods
- Not stated in the paper.
- The article is a narrative review that synthesizes prior studies, surveillance reports, and policy examples on antimicrobial use in food production and resistance development.
- Its main analysis is qualitative: it links mechanisms of resistance with historical and current evidence from livestock, poultry, aquaculture, farm workers, and human infections.
## Limitations
- The paper states that “the actual impact of the effect of antimicrobial use and the resultant resistance development by human pathogenic bacteria is a topic of intense debate.”
- It also notes that “a multiplicity of factors contribute to AMR development,” suggesting antimicrobial use is not the only driver.
- Evident from the text: the paper is a broad review rather than an original empirical study, so its conclusions depend on previously published studies and examples rather than a single unified dataset.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
0 Valid · 2 Not valid · 28 Not checked · 8 Own results and interpretations
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“However, there is no evidence to directly link human infections of LA-MRSA to their livestock origin.”
§ The Food Production Environment and the Development of Antimicrobial Resistance in Human Pathogens of Animal Origin > 4. Antimicrobial Use and the Development of Resistance in Food Production Environments The use of antimicrobials in animal husbandry and the resultant development of antibiotic resistance in bacteria is recognized as a potential human health concern for various reasons, such as: (i) the antibiotic-resistant bacteria associated with animals may be pathogenic to humans; (ii) antibiotic-resistant bacteria can be easily transmitted to humans via food from farm animals; (iii) these antibiotic-resistant bacteria can spread to the environment through animal waste leading to wider dissemination; (iv) bacteria can transmit their resistance genotypes to human pathogens not associated with the animals via genetic element transfer mechanisms [79]. Several studies have shown that the regular use of antimicrobials in food animals and birds results in the development of antimicrobial resistance among commensal bacteria. A recent study involving seven European countries found a strong correlation between the levels of antimicrobials used and the resistances of commensal E. coli isolates towards those antibiotics in pigs, poultry and cattle [80]. The use of low-dose, sub-therapeutic concentrations in animal systems results in the selection of a resistant population of bacteria which colonize the animal surface, the gut and the rearing environment [81,82]. The effect of antimicrobial use is not restricted to the farm environment. Since a substantial quantity of antimicrobials is excreted by the animals via feces, environmental contamination with sub-lethal concentrations of antimicrobials occurs [83]. Environmental bacteria exposed to sub-lethal concentrations of antimicrobials can develop resistance, and through genetic exchange mechanisms, the resistance phenotype gets gradually disseminated among pathogenic and non-pathogenic bacteria. An environmental resistome builds up which can lead to wider dissemination of resistant bacteria [84]. The presence of antibiotics in foods consumed by humans has its own implications on antibiotic resistance development by the human gut microbiome [85]. The connection between antibiotic use and resistance development was first observed in E. coli isolated from the gut of chickens fed with streptomycin [86]. Some of the important pathogens of particular consideration with respect to their development of resistance to the above three classes of drugs include Clostridium difficile, Campylobacter, Salmonella, Shigella, and S. aureus. Currently, several antimicrobials of human medical use are being used in livestock, poultry, and aquaculture (Table 2). Some of these such as the fluoroquinolones are critical for the treatment of Gram-negative infections in humans, and their use in food animals may jeopardize the efficacy of these antibiotics due to the development of resistance in pathogens of zoonotic potential [87]. Scientifically based investigations suggest a strong relationship between antibiotic use in food animals and the development of antibiotic resistance by bacteria associated with farm animals [88,89,90]. There are numerous documented instances in which the introduction of an antibiotic as an AGP or for the treatment of specific infections resulted in the emergence of antibiotic-resistant bacterial variants [91]. Food animals and workers on farms using AGPs harbor more antibiotic-resistant bacteria compared to those from farms not using AGPs [92]. Antibiotic-resistant bacteria associated with food animals has resulted in their dissemination via the food chain and into the environment, and in farm workers being the carriers of such bacteria [81,93]. A study in the USA revealed that poultry workers had a 32-times-higher risk of carrying gentamicin-resistant E. coli compared with community referents [94]. It has been experimentally shown that the use of avoparcin in chicks resulted in the development of vancomycin resistance by Enterococcus faecium (VRE), and such bacteria could be transmitted to humans via their consumption of meat contaminated with VRE [74]. Prohibition of avoparcin in European Union countries in 1997 resulted in a decrease of VRE in poultry and in the community [95]. The decrease in the use of tylosin during 1998 and 1999 was followed by a decrease in erythromycin resistance among E. faecium and E. faecalis isolates from pigs [96]. An increased occurrence of virginiamycin resistance among E. faecium isolates in broilers correlated with the increased use of virginiamycin during 1995 to 1997 in Denmark, and the subsequent ban on the use of virginiamycin in 1998 resulted in a decrease in the resistance [96]. A strong correlation between the use of sub-therapeutic concentrations of tetracycline, alone or in combination with sulfamethazine, and the carriage of resistant strains of Campylobacter species in feedlot cattle has been demonstrated [97]. Quinolonesand third and fourth generation cephalosporins are important in treating salmonellosis in humans, and their widespread use in animal husbandry has selected for resistant strains that can potentially jeopardize their human clinical application [98]. A surveillance study in the USA revealed a strong association between the rise in ciprofloxacin resistance in Campylobacter spp. and the use of fluoroquinolones such as sarafloxacin and enrofloxacin in food-producing animals [99]. A sharp rise in ciprofloxacin resistance in Campylobacter as a result of the use of fluoroquinolones in food-producing animals has been reported from Denmark, Spain and the Netherlands [88,100]. The introduction of fluoroquinolones for the treatment of respiratory diseases led to the emergence of fluoroquinolone-resistant Campylobacter [88,101]. The use of third generation cephalosporins led to an increase in the number of cephalosporin-resistant Salmonella strains [102]. A study by Alexander et al. [103] has shown that sub-therapeutic administration of tetracycline in combination with sulfamethazine increased the prevalence of tetracycline- and AMP-resistant E. coli in cattle. The development of multidrug resistance in E. coli and Salmonella in swine fed with antimicrobial feed has been reported by several investigators [104,105,106,107]. Similarly, it has been reported that macrolides, which are widely used in food animals, result in the selection of macrolide-resistant Campylobacter spp. [98]. Considering the importance of macrolides in the treatment of Campylobacter infections in children, its use in food animals requires critical rethinking. Another serious pathogen associated with livestock and which poses the danger of transmission via food-producing animals is the methicillin-resistant Staphylococcus aureus (MRSA). A particular sequence type, ST398, of livestock-associated MRSA (LA-MRSA) has also been found in farm facilities and in farm workers [108]. However, there is no evidence to directly link human infections of LA-MRSA to their livestock origin. Historically, when antimicrobial agents were first used in agriculture, such as in food production environments, bacterial multidrug-resistant variants of S. enterica and E. coli soon emerged [109,110]. Shortly after the emergence of this multidrug resistance occurred, transfer of the resistance determinants was detected in the form of plasmids, thus facilitating their movement from food animals to humans and the subsequent transmission to the gastrointestinal tract of new human hosts [91,111]. Together, mobile genetic transfer elements (e.g., bacteriophages, plasmids, gene cassettes, integrons, transposons) and various modes of infection transmission (e.g., direct food animal to human and food-borne) have facilitated the spread of newly emerged resistance determinants from food animals and their food products to humans and their communities, as a consequence of exposure to sub-lethal concentrations of antimicrobial agents [112,113]. These sub-inhibitory concentrations of antimicrobial agents used in agriculture exert selective evolutionary pressures upon the populations of bacteria that reside in food production environments, resulting in the emergence and subsequent predominance of multidrug-resistant variants [52,114]. Such multidrug-resistant variants have included Gram-positive and –negative bacteria such as Enterococcus spp. [115], Lactococcus spp. [116], Lactobacillus spp. [117], S. aureus [118], and Gram-negative bacteria such as E. coli [119], Campylobacter spp. [120], Listeria monocytogenes [121] and S. enterica [54,122]. Consequently, it has since been widely documented that antimicrobial use in food animals correlates not only with the emergence of bacterial multidrug resistance but also with the spread of infectious diseases that are recalcitrant to efficacious chemotherapy in humans [92,114,123,124]. Policy practices implemented in Europe in which antimicrobial non-therapeutic uses are completely banned (e.g., avoparcin and virginiamycin) in agriculture settings have resulted in reductions in both the prevalence of multidrug-resistant pathogens and in the minimal inhibitory concentrations (MICs) for clinically relevant antimicrobials, such as vancomycin [92,124]. Despite the extensive amount of work over a span of 50 years definitively demonstrating an association between antimicrobial agents and the incidence and prevalence of multiple drug-resistant microorganisms in food production circles [125], the issue remains surprisingly controversial in agriculture, but apparently not in human healthcare settings. Therefore, with respect to antimicrobial usage in agriculture, more work will be necessary to gain a fuller understanding of the nature and extent of the resistance prevalence problem, the overall efficacy of the antimicrobial bans, and the resulting improvement in human health [92]. A review study by the European Food Safety Authority (EFSA) and the European Medicines Agency (EMA) on the impact of measures taken to reduce the use of antimicrobials in food-producing animals on the occurrence of antimicrobial resistance (AMR) in bacteria from food-producing animals suggested an association between the reduction in antimicrobial use and reduced AMR [126], although a multiplicity of factors contribute to AMR development. An integrated approach involving different stakeholders to reduce the use of antimicrobials in animals has been recommended, which emphasizes better management practices to reduce the risks of disease, searching for alternative strategies such as competitive exclusion of pathogens, immunostimulants, probiotics, and bacteriophages, and avoiding the preventive use of antimicrobials, etc. [126].
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“These sub-inhibitory concentrations of antimicrobial agents used in agriculture exert selective evolutionary pressures upon the populations of bacteria that reside in food production environments, resulting in the emergence and subsequent predominance of multidrug-resistant variants [52,114].”
§ The Food Production Environment and the Development of Antimicrobial Resistance in Human Pathogens of Animal Origin > 4. Antimicrobial Use and the Development of Resistance in Food Production Environments The use of antimicrobials in animal husbandry and the resultant development of antibiotic resistance in bacteria is recognized as a potential human health concern for various reasons, such as: (i) the antibiotic-resistant bacteria associated with animals may be pathogenic to humans; (ii) antibiotic-resistant bacteria can be easily transmitted to humans via food from farm animals; (iii) these antibiotic-resistant bacteria can spread to the environment through animal waste leading to wider dissemination; (iv) bacteria can transmit their resistance genotypes to human pathogens not associated with the animals via genetic element transfer mechanisms [79]. Several studies have shown that the regular use of antimicrobials in food animals and birds results in the development of antimicrobial resistance among commensal bacteria. A recent study involving seven European countries found a strong correlation between the levels of antimicrobials used and the resistances of commensal E. coli isolates towards those antibiotics in pigs, poultry and cattle [80]. The use of low-dose, sub-therapeutic concentrations in animal systems results in the selection of a resistant population of bacteria which colonize the animal surface, the gut and the rearing environment [81,82]. The effect of antimicrobial use is not restricted to the farm environment. Since a substantial quantity of antimicrobials is excreted by the animals via feces, environmental contamination with sub-lethal concentrations of antimicrobials occurs [83]. Environmental bacteria exposed to sub-lethal concentrations of antimicrobials can develop resistance, and through genetic exchange mechanisms, the resistance phenotype gets gradually disseminated among pathogenic and non-pathogenic bacteria. An environmental resistome builds up which can lead to wider dissemination of resistant bacteria [84]. The presence of antibiotics in foods consumed by humans has its own implications on antibiotic resistance development by the human gut microbiome [85]. The connection between antibiotic use and resistance development was first observed in E. coli isolated from the gut of chickens fed with streptomycin [86]. Some of the important pathogens of particular consideration with respect to their development of resistance to the above three classes of drugs include Clostridium difficile, Campylobacter, Salmonella, Shigella, and S. aureus. Currently, several antimicrobials of human medical use are being used in livestock, poultry, and aquaculture (Table 2). Some of these such as the fluoroquinolones are critical for the treatment of Gram-negative infections in humans, and their use in food animals may jeopardize the efficacy of these antibiotics due to the development of resistance in pathogens of zoonotic potential [87]. Scientifically based investigations suggest a strong relationship between antibiotic use in food animals and the development of antibiotic resistance by bacteria associated with farm animals [88,89,90]. There are numerous documented instances in which the introduction of an antibiotic as an AGP or for the treatment of specific infections resulted in the emergence of antibiotic-resistant bacterial variants [91]. Food animals and workers on farms using AGPs harbor more antibiotic-resistant bacteria compared to those from farms not using AGPs [92]. Antibiotic-resistant bacteria associated with food animals has resulted in their dissemination via the food chain and into the environment, and in farm workers being the carriers of such bacteria [81,93]. A study in the USA revealed that poultry workers had a 32-times-higher risk of carrying gentamicin-resistant E. coli compared with community referents [94]. It has been experimentally shown that the use of avoparcin in chicks resulted in the development of vancomycin resistance by Enterococcus faecium (VRE), and such bacteria could be transmitted to humans via their consumption of meat contaminated with VRE [74]. Prohibition of avoparcin in European Union countries in 1997 resulted in a decrease of VRE in poultry and in the community [95]. The decrease in the use of tylosin during 1998 and 1999 was followed by a decrease in erythromycin resistance among E. faecium and E. faecalis isolates from pigs [96]. An increased occurrence of virginiamycin resistance among E. faecium isolates in broilers correlated with the increased use of virginiamycin during 1995 to 1997 in Denmark, and the subsequent ban on the use of virginiamycin in 1998 resulted in a decrease in the resistance [96]. A strong correlation between the use of sub-therapeutic concentrations of tetracycline, alone or in combination with sulfamethazine, and the carriage of resistant strains of Campylobacter species in feedlot cattle has been demonstrated [97]. Quinolonesand third and fourth generation cephalosporins are important in treating salmonellosis in humans, and their widespread use in animal husbandry has selected for resistant strains that can potentially jeopardize their human clinical application [98]. A surveillance study in the USA revealed a strong association between the rise in ciprofloxacin resistance in Campylobacter spp. and the use of fluoroquinolones such as sarafloxacin and enrofloxacin in food-producing animals [99]. A sharp rise in ciprofloxacin resistance in Campylobacter as a result of the use of fluoroquinolones in food-producing animals has been reported from Denmark, Spain and the Netherlands [88,100]. The introduction of fluoroquinolones for the treatment of respiratory diseases led to the emergence of fluoroquinolone-resistant Campylobacter [88,101]. The use of third generation cephalosporins led to an increase in the number of cephalosporin-resistant Salmonella strains [102]. A study by Alexander et al. [103] has shown that sub-therapeutic administration of tetracycline in combination with sulfamethazine increased the prevalence of tetracycline- and AMP-resistant E. coli in cattle. The development of multidrug resistance in E. coli and Salmonella in swine fed with antimicrobial feed has been reported by several investigators [104,105,106,107]. Similarly, it has been reported that macrolides, which are widely used in food animals, result in the selection of macrolide-resistant Campylobacter spp. [98]. Considering the importance of macrolides in the treatment of Campylobacter infections in children, its use in food animals requires critical rethinking. Another serious pathogen associated with livestock and which poses the danger of transmission via food-producing animals is the methicillin-resistant Staphylococcus aureus (MRSA). A particular sequence type, ST398, of livestock-associated MRSA (LA-MRSA) has also been found in farm facilities and in farm workers [108]. However, there is no evidence to directly link human infections of LA-MRSA to their livestock origin. Historically, when antimicrobial agents were first used in agriculture, such as in food production environments, bacterial multidrug-resistant variants of S. enterica and E. coli soon emerged [109,110]. Shortly after the emergence of this multidrug resistance occurred, transfer of the resistance determinants was detected in the form of plasmids, thus facilitating their movement from food animals to humans and the subsequent transmission to the gastrointestinal tract of new human hosts [91,111]. Together, mobile genetic transfer elements (e.g., bacteriophages, plasmids, gene cassettes, integrons, transposons) and various modes of infection transmission (e.g., direct food animal to human and food-borne) have facilitated the spread of newly emerged resistance determinants from food animals and their food products to humans and their communities, as a consequence of exposure to sub-lethal concentrations of antimicrobial agents [112,113]. These sub-inhibitory concentrations of antimicrobial agents used in agriculture exert selective evolutionary pressures upon the populations of bacteria that reside in food production environments, resulting in the emergence and subsequent predominance of multidrug-resistant variants [52,114]. Such multidrug-resistant variants have included Gram-positive and –negative bacteria such as Enterococcus spp. [115], Lactococcus spp. [116], Lactobacillus spp. [117], S. aureus [118], and Gram-negative bacteria such as E. coli [119], Campylobacter spp. [120], Listeria monocytogenes [121] and S. enterica [54,122]. Consequently, it has since been widely documented that antimicrobial use in food animals correlates not only with the emergence of bacterial multidrug resistance but also with the spread of infectious diseases that are recalcitrant to efficacious chemotherapy in humans [92,114,123,124]. Policy practices implemented in Europe in which antimicrobial non-therapeutic uses are completely banned (e.g., avoparcin and virginiamycin) in agriculture settings have resulted in reductions in both the prevalence of multidrug-resistant pathogens and in the minimal inhibitory concentrations (MICs) for clinically relevant antimicrobials, such as vancomycin [92,124]. Despite the extensive amount of work over a span of 50 years definitively demonstrating an association between antimicrobial agents and the incidence and prevalence of multiple drug-resistant microorganisms in food production circles [125], the issue remains surprisingly controversial in agriculture, but apparently not in human healthcare settings. Therefore, with respect to antimicrobial usage in agriculture, more work will be necessary to gain a fuller understanding of the nature and extent of the resistance prevalence problem, the overall efficacy of the antimicrobial bans, and the resulting improvement in human health [92]. A review study by the European Food Safety Authority (EFSA) and the European Medicines Agency (EMA) on the impact of measures taken to reduce the use of antimicrobials in food-producing animals on the occurrence of antimicrobial resistance (AMR) in bacteria from food-producing animals suggested an association between the reduction in antimicrobial use and reduced AMR [126], although a multiplicity of factors contribute to AMR development. An integrated approach involving different stakeholders to reduce the use of antimicrobials in animals has been recommended, which emphasizes better management practices to reduce the risks of disease, searching for alternative strategies such as competitive exclusion of pathogens, immunostimulants, probiotics, and bacteriophages, and avoiding the preventive use of antimicrobials, etc. [126].
What the sources say
- Not checked yetcites [52] Andersen, 2015, Multidrug efflux pumps from Enterobacteriaceae, Vibrio cholerae and Staphylococcus aureus bacterial food pathogens, Int. J. Environ. Res. Public Health source
- Not checked yetcites [114] Witte, 2000, Selective pressure by antibiotic use in livestock, Int. J. Antimicrob. Agents source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“The use of antibiotics for short-term gains has inflicted a long-lasting negative impact on human health and in the environment [14].”
§ The Food Production Environment and the Development of Antimicrobial Resistance in Human Pathogens of Animal Origin > 1. Introduction
What the sources say
- Not checked yetcites [14] Chattopadhyay, 2014, Use of antibiotics as feed additives: A burning question, Front. Microbiol. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In the United States, nearly 80% of the antibiotics produced are used in animal husbandry [11].”
§ The Food Production Environment and the Development of Antimicrobial Resistance in Human Pathogens of Animal Origin > 1. Introduction
What the sources say
- Not checked yetcites [11] United States Food and Drug Administration (2014). Summary Report on Antimicrobials Sold or Distributed for Use in Food-Producing Animals, United States Food and Drug Administration.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Indiscriminate use of antibiotics for purposes other than treatment of infections has resulted in the emergence of antibiotic-resistant pathogens in food production environments, and such pathogens can cause infections in humans that are difficult to treat or control.”
§ The Food Production Environment and the Development of Antimicrobial Resistance in Human Pathogens of Animal Origin > 1. Introduction
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims
Create a free account to see all 38 claims and to verify the 37 references still open.
- It may state two separate claims as one. 10
- Probably not a substantial claim. 3
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Antibiotics that have been used in the management of cholera cases for decades such as tetracyclines, which include doxycycline and tetracycline, have been associated with the presence of IncC conjugative plasmids.15,16,17”
From Geographical distribution and antibiotics susceptibility patterns of toxigenic Vibrio cholerae isolates from Kisumu County, Kenya (2020) · cites this paper as [16]
Citations
Cites
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784 · cited 1×
“However, bacterial pathogens soon exhibited the signs of surviving the lethal effects of antimicrobials, and the first penicillin-resistant Staphylococcus was reported soon after the introduction of penicillin in 1946, although penicillinases were discovered considerably before the discovery of penicillin itself, sugg…”
BackgroundAntibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Global trends in antimicrobial use in food animals
Van Boeckel, T. P., Brower, C., Gilbert, M., Grenfell, B. T., Levin, S. A., Robinson, T. P., Teillant, A., & Laxminarayan, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1503141112 · Cited by 3,973 · cited 2×
“Global antimicrobial use in food animals (a) Major users of antimicrobials in livestock in 2010; (b) Major users of antimicrobials in livestock in 2030 (projected) [65].”
BackgroundFood Animals and Antimicrobials: Impacts on Human Health
Marshall, B. M., & Levy, S. B. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00002-11 · Cited by 2,241 · cited 7×
“Considering the potential link between the use of antibiotics and their effect on human health, the World Health Organization (WHO) recommended the termination of AGPs belonging to classes of antibiotics used in human treatment and cautious application of other AGPs with routine monitoring of resistance development [1…”
BackgroundInfluentialMobile genetic elements: the agents of open source evolution
Frost, L. S., Leplae, R., Summers, A. O., & Toussaint, A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1235 · Cited by 1,847 · cited 1×
“, direct food animal to human and food-borne) have facilitated the spread of newly emerged resistance determinants from food animals and their food products to humans and their communities, as a consequence of exposure to sub-lethal concentrations of antimicrobial agents [112,113].”
BackgroundOuter membrane permeability and antibiotic resistance
Delcour, A. H. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2008.11.005 · Cited by 1,762 · cited 1×
“This mechanism is referred to as drug permeability reduction and prevents access of antimicrobial agents to their intracellular drug targets, thus conferring antimicrobial resistance [35,36].”
BackgroundMechanisms of Antimicrobial Resistance in Bacteria
Tenover, F. C. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.03.011 · Cited by 1,682
A brief history of the antibiotic era: lessons learned and challenges for the future
Aminov, R. I. (2010) · Frontiers in Microbiology · doi:10.3389/fmicb.2010.00134 · Cited by 1,628 · cited 1×
“Infectious diseases were thought to have been controlled, and the magic of antibiotics continued for a specific period of time during the mid-20th century, called the “golden era of antibiotic chemotherapy” [2].”
BackgroundThe Challenge of Efflux-Mediated Antibiotic Resistance in Gram-Negative Bacteria
Li, X.-Z., Plésiat, P., & Nikaido, H. (2015) · Clinical Microbiology Reviews · doi:10.1128/cmr.00117-14 · Cited by 1,614 · cited 2×
“Bacteria harboring these determinants are essentially resistant to clinically important antimicrobials such as the aminoglycosides, the β-lactams, the fluoroquinolones and the chloramphenicols [37].”
BackgroundSampling the Antibiotic Resistome
D'Costa, V. M., McGrann, K. M., Hughes, D. W., & Wright, G. D. (2006) · Science · doi:10.1126/science.1120800 · Cited by 1,594 · cited 1×
“However, bacterial pathogens soon exhibited the signs of surviving the lethal effects of antimicrobials, and the first penicillin-resistant Staphylococcus was reported soon after the introduction of penicillin in 1946, although penicillinases were discovered considerably before the discovery of penicillin itself, sugg…”
Background
Research works printed but not linked: 6
- Kumar, S., Floyd, J.T., He, G., and Varela, M.F. (2013). Bacterial Antimicrobial Efflux Pumps of the MFS and Mate Transporter Families: A Review, Research Signpost Inc.
- Prescott, J., and Baggot, J. (1993). Antimicrobial Therapy in Veterinary Medicine, Iowa State University Press. [2nd ed.].
- (2015). Antimicrobials in Agriculture and the Environment: Reducing Unnecessary Use and Wastage. The Review on Antimicrobial Resistance, Antimicrobial Resistance Review (AMR).
- NIAA (2011, January 26–27). Antibiotic Use in Food Animals: A Dialogue for a Common Purpose. Proceedings of the Symposium by National Institute for Animal Agriculture and Conducted, Chicago, IL, USA.
- Vaughn, M., and Copeland, D. (2004, January 6–9). Is there human health harm following fluoroquinolone use in poultry?. Proceedings of the Fifty-Third Western Poultry Disease Conference, Sacramento, CA, USA.
- FAO (2007, January 26–30). Joint FAO/WHO/OIE expert meeting on critically important antimicrobials. Proceedings of the FAO/WHO/OIE Expert Meeting FAO Headquarters, Rome, Italy.
Cited by
Items 101–197 of 197
Wang, M., Chen, S., Zhang, J.-X., He, X.-X., Xiong, W., & Sun, Y. (2018) · Journal of Applied Microbiology · doi:10.1111/jam.14065 · Cited by 9
“Numerous countries have banned the use of tetracycline, sulphonamides and the quinolone antibiotics as growth promoters in animal feed (Lekshmi et al. 2017).”
BackgroundInfluentialKumar, S. H., Lekshmi, M., Stephen, J., Ortiz-Alegria, A., Ayitah, M., & Varela, M. F. (2023) · Archives of Microbiology · doi:10.1007/s00203-023-03731-5 · Cited by 8
“Apart from being a therapeutic drug, these agents are also administered in sub-therapeutic doses among livestock, poultry, and aquaculture to prevent disease and promote growth (Lekshmi et al. 2017).”
BackgroundSelf-citationInnes, G. K., Patton, A. N., Nachman, K. E., Casey, J. A., Stapleton, G. S., Abraham, A. G., Price, L. B., Tartof, S. Y., & Davis, M. F. (2023) · Scientific Reports · doi:10.1038/s41598-023-48197-z · Cited by 8
Mukherjee, S., Lekshmi, M., Parvathi, A., Nayak, B. B., & Kumar, S. H. (2021) · Archives of Microbiology · doi:10.1007/s00203-021-02411-6 · Cited by 8
Self-citationDíaz, L., Gutiérrez, S., Moreno‐Switt, A. I., Hervé-Claude, L. P., Hamilton-West, C., Padola, N. L., Navarrete, P., Reyes-Jara, A., Meng, J., González‐Escalona, N., et al. (2021) · Animals · doi:10.3390/ani11082388 · Cited by 10
Tilahun, H. E., & Efa, D. A. (2025) · BMC Veterinary Research · doi:10.1186/s12917-025-05188-8 · Cited by 9
“In many countries, antimicrobials are also used for non-therapeutic purposes, such as enhancing feed efficiency and promoting growth in live-stock [9, 10].”
Diseases and Antimicrobial Use in Aquaculture
Stephen, J., Mukherjee, S., Lekshmi, M., & Kumar, S. H. (2023) · Springer eBooks · doi:10.1007/978-981-19-9279-7_15 · Cited by 7
Self-citationSlimen, I. B., Boa, M. V., Lengliz, S., Kefi, B. B., Samti, H., Abbassi, M. S., M’Hamdi, N., Chaveriat, L., Martin, P., Abderrabba, M., et al. (2025) · Frontiers in Animal Science · doi:10.3389/fanim.2025.1563915 · Cited by 7
“Regrettably, the anarchic use of AGPs has led to antibiotic resistance, which has resulted in serious public health risks (Lekshmi et al., 2017; Jez ̇ ak and Kozajda, 2022).”
Igbinosa, I. H., & Chiadika, C. (2021) · African Journal of Clinical and Experimental Microbiology · doi:10.4314/ajcem.v22i2.15 · Cited by 7
Navarro, M., Alonso, L. L., Capparelli, A. L., & Marino, D. J. G. (2022) · Agricultural Water Management · doi:10.1016/j.agwat.2022.107963 · Cited by 7
Deb, P., Das, T., Nath, C., Ahad, A., & Chakraborty, P. (2020) · Journal of Advanced Veterinary and Animal Research · doi:10.5455/javar.2020.g466 · Cited by 7
Reski, S., Mahata, L. E., Rizal, Y., & Dewi, Y. L. (2026) · Veterinary World · doi:10.14202/vetworld.2026.224-263 · Cited by 6
Gong, Y., Peng, Q., Qiao, Y., Tian, D., Zhang, Y.-W., Xiong, X., He, M., Xu, X., & Shi, B. (2024) · Antibiotics · doi:10.3390/antibiotics13030217 · Cited by 6
“Many countries have banned the use of antibiotic growth promoters and the application of antibiotics that are important to human medicine in animals [2].”
BackgroundReducing residual chlortetracycline in wastewater using a whole-cell biocatalyst
Liu, M., Wang, C., Qi, X.-E., Du, S., & Ni, H. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116717 · Cited by 6
Antimicrobial Applications in Agriculture: A Review
Nor, Y. A., Johari, F., Ariffin, F. N. K., Ali, A. M. M., & Khairudin, N. H. (2018) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.12.4.17 · Cited by 7
Nelapati, S., Tumati, S. R., Thirtham, M., Pushpa, R. N. R., Kamisetty, A. K., & Ch, B. K. (2020) · Letters in Applied Microbiology · doi:10.1111/lam.13281 · Cited by 6
Ismaila, M. S., Thomas-Rhoden, A., Neptune, A., Sookram, K., Gopaul, S., Padarath, T., Persad, A. K., Georges, K. C., & Sundaram, V. (2022) · Antibiotics · doi:10.3390/antibiotics11070885 · Cited by 6
Garcia, J. D., Huff, A. G., & Huff, E. S. (2020) · Animal Production Science · doi:10.1071/an18765 · Cited by 6
Hriouech, S., Akhmouch, A. A., Tanghort, M., Chefchaou, H., Mzabi, A., Chami, N., & Remmal, A. (2020) · Veterinary Medicine International · doi:10.1155/2020/8824008 · Cited by 7
“Such use induces the selection of multidrug-resistant bacteria, which in turn reduces the efficacy of antibiotic therapy in both animals and humans that are colonized with resistant bacteria [1, 6].”
BackgroundLow temperatures do not impair the bacterial plasmid conjugation on poultry meat
Campos, I. C., Saraiva, M. D. M. S., Benevides, V. P., Ferreira, T. S., Ferreira, V. A., de Almeida, A. M., & Berchieri, Â. (2024) · Brazilian Journal of Microbiology · doi:10.1007/s42770-023-01230-9 · Cited by 5
“Many factors drive the emergence of antimicrobial resistance (AMR), especially the indiscriminate use of these drugs in food-producing animals [1, 2].”
Masse, M. T., Aloys, R. J. S., & Betbui, B. T. (2021) · International Journal of Health Sciences and Research · doi:10.52403/ijhsr.20210405 · Cited by 5
Feeding laying hens with lactobacilli improves internal egg quality and animal health
Mörschbächer, A. P., Berghahn, E., Shibuya, F. Y., Cardoso, M. L., Ulguim, G. K., Michelon, N. D. F., Torgeski, N., Vivian, T. P., Wissmann, D., de Camargo, F. C. D. L. S., et al. (2023) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-023-03820-z · Cited by 5
“Global concerns regarding the spread of antimicro-bial-resistant genes in human pathogens have resulted in the restrictions, or banning, the use of subtherapeutic antimicrobial molecules as animal growth promoters in many countries (Lekshmi et al. 2017; Aidara-Kane et al. 2018).”
BackgroundAborah, E., Ayitah, M., Boafo, K. F., Ortiz-Alegria, A., Lekshmi, M., Dhanush, C. K., Kumar, S. H., & Varela, M. F. (2025) · Exploration of Drug Science · doi:10.37349/eds.2025.100897 · Cited by 5
Self-citationKerek, Á., Szabó, Á., Dobra, P. F., Bárdos, K., Paszerbovics, B., Bata, Z., Molnár-Nagy, V., Jerzsele, Á., & Ózsvári, L. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1570387 · Cited by 5
“Following the World Health Organization’s recommendations to minimize the use of critically important antimicrobials in human medicine (30).”
InfluentialPalupi, M. F., Maheshwari, H., Darusman, H. S., Sudarnika, E., & Wibawan, I. W. T. (2018) · jurnal veteriner · doi:10.19087/jveteriner.2018.19.2.196 · Cited by 5
КОНТРОЛЬ ВМІСТУ ЗАЛИШКОВИХ КІЛЬКОСТЕЙ АНТИБІОТИКІВ У ПРОДУКТАХ ТВАРИННОГО ПОХОДЖЕННЯ
Klyap, N., Krachkovska, O., Маслюк, А. В., Мостіпан, К. С., & Київська, Г. В. (2020) · Вісник Полтавської державної аграрної академії · doi:10.31210/visnyk2020.02.23 · Cited by 5
Jassim, A. A., & Al‐Gburi, N. M. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns3.7763 · Cited by 5
“…βlactam, and aminoglycosides is considered alarming, as they are used for the treatment of invasive Salmonellosis and subsequently, multi-drug resistant Salmonellae constituted a public health hazard and potentially affected the efficacy of medications in humans (Lekshmi et al., 2017).”
BackgroundΑνδρίτσος, Ν. Δ., Ματαράγκα, Α., Tzimotoudis, N., Chatzopoulou, A.-S., Kotsikori, M., & Ikonomopoulos, J. (2025) · Veterinary Sciences · doi:10.3390/vetsci12090844 · Cited by 4
“Increased AMR of bacterial pathogens in food animals can lead to human infections through the consumption of food with antibiotic-resistant microorganisms, which may confer diseases difficult to treat [8].”
Mudenda, S., Chizimu, J. Y., Daka, V., Kasanga, M., Mufwambi, W., Mwangilwa, K., Hangoma, J. M., Gardner, P. N., Chileshe, C., Mudenda, N. B., et al. (2025) · Antibiotics · doi:10.3390/antibiotics14111126 · Cited by 5
“The use of antimicrobials as growth promoters, a practice discouraged by global health agencies, further exacerbates the risk of AMR transmission from animals to humans through the food chain and the environment [35,36].”
Ndobeni, T. N., Magwedere, K., & Qekwana, D. N. (2023) · Veterinary World · doi:10.14202/vetworld.2023.2236-2243 · Cited by 4
“Several Salmonella spp. have been linked to human foodborne illnesses [13], mostly due to the consumption of poultry products [5, 14–18].”
Hazards of Using Antibiotic Growth Promoters in the Poultry Industry
Alagawany, M. M., El-Hack, M. E. A., Saeed, M., Khan, M. S., Kamboh, A. A., Siddique, F., Raza, A., Farag, M. R., & Mahgoub, S. A. (2022) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815049015122010004 · Cited by 3
Kizerwetter‐Świda, M., & Pławińska-Czarnak, J. (2017) · Medycyna Weterynaryjna · doi:10.21521/mw.5789 · Cited by 3
Nicola, I., Gallina, G., Cagnotti, G., Gianella, P., Valentini, F., D’Angelo, A., & Bellino, C. (2021) · Animals · doi:10.3390/ani11071925 · Cited by 4
Nirgund, J., Purana, K. N., Selvakumar, D., Kumar, N. S., & Sil, S. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-823426-6.00023-1 · Cited by 3
Antimicrobial resistance of enteric pathogens in the Military Health System, 2009 – 2019
Ashbaugh, H. R., Pomeroy, C. D., Baishya, M. L., Creppage, K. E., Bazaco, S. L., Johnson, M., Matsumoto, K., Bhattarai, U., Seliga, N., Graf, P. C. F., et al. (2022) · BMC Public Health · doi:10.1186/s12889-022-14466-1 · Cited by 4
“The regular use of antimicrobial agents in food animals has generated resistance in commensal bacteria, which presents a potential source for human acquisition of resistance from the consumption of food producing animals [14].”
BackgroundAntimicrobial consumption in food animals in Fiji: Analysis of the 2017 to 2021 import data
Magiri, R. B., Dissanayake, C., & Okello, W. O. (2022) · Frontiers in Antibiotics · doi:10.3389/frabi.2022.1055507 · Cited by 3
“The prudent use of antimicrobial agents in food producing animals is necessary to prevent the development and spread of antimicrobial resistance between animals and human (Anthony et al., 2001; Lekshmi et al., 2017; Aidara-Kane et al., 2018).”
BackgroundDelgado, D. L. C., Guzmán-Sànchez, T. J., Ferro-Villamizaro, S. A., Díaz-Gélvez, C. A., & Bernal-Pérez, M. Á. (2022) · Spei Domus · doi:10.16925/2382-4247.2022.02.05 · Cited by 3
Diseases and Antimicrobial Use in Aquaculture
Stephen, J., Mukherjee, S., Lekshmi, M., & Kumar, S. H. (2023) · Springer eBooks · doi:10.1007/978-981-16-9723-4_15-1 · Cited by 3
Self-citationAntibiotic Resistance Characteristics and Prevalence in Kitfo, an Ethiopian Beef Tartar
Eshetea, B. B., Addy, N., Ewing, L., Beaubrun, J. J.-G., & Eribo, B. E. (2020) · Journal of Food Protection · doi:10.4315/jfp-20-230 · Cited by 3
Microbiological quality and Salmonella-related food safety risks in commercial and free-range eggs
Aguiar, N. T., da Silva, E. P. R., Nascimento, C. A., Alves, K. F., da Costa, L. B. S. B., & Júnior, J. C. R. (2026) · Food Control · doi:10.1016/j.foodcont.2026.112083 · Cited by 3
Guo, Q., Che, Z., Hu, F., Wu, J., Lv, S., Zhao, W., Li, S., Wang, Y., & Peng, X. (2026) · Poultry Science · doi:10.1016/j.psj.2026.107207 · Cited by 2
“Restrictions on antimicrobial use in livestock production have increased the need for alternative strategies that can maintain animal health while reducing selection pressure for antimicrobial resistance (Lekshmi, et al., 2017).”
Shanduka, R. B., Sekano, K., Adedokun, S. A., & Mnisi, C. M. (2026) · Poultry Science · doi:10.1016/j.psj.2026.107309 · Cited by 2
“Amongst these, prophylactic and growth-promoting uses at subtherapeutic levels, are most strongly associated with the development of AMR due to the continuous exposure of microbial populations (Lekshmi et al., 2017).”
Pena, R. H. R., Freitas, F., & de Castro, B. G. (2021) · Arquivos do Instituto Biológico · doi:10.1590/1808-1657000702019 · Cited by 2
Saber, H., Abadi, V. M. M., Hassanshahian, M., & Ranjbar, A. H. (2022) · Proceedings of the National Academy of Sciences India Section B Biological Sciences · doi:10.1007/s40011-021-01307-1 · Cited by 2
“Excessive use of antibiotics in the process of producing animal food can lead to the development of a phenomenon called drug resistance in bacteria [1].”
BackgroundAntibiotics in Livestock and Their Effects on the Human Health: Mini Review
Rana, M. S., & Hur, S. J. (2022) · Resources Science Research · doi:10.52346/rsr.2022.4.1.12 · Cited by 3
“However, the use of antibiotics in food production also led to the spread and development of antimicrobial resistance (AMR) (Lekshmi et al., 2017).”
BackgroundAntimicrobial Use in Animal Food Production
Garvey, M. (2022) · Springer eBooks · doi:10.1007/978-3-031-07434-9_6 · Cited by 5
Endosymbiotic interactions of actinobacteria with the insects
Gopikrishnan, V., Manikkam, R., Krupakar, P., Manigundan, K., Baskaran, A., & Reshma, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99334-0.00001-3 · Cited by 2
Enejiyon, S. O., Ahmad, N. H., Fasasi, R. A., Adabara, N. U., Oyewole, O. A., Adetunji, C. O., Eniola, K. I. T., & Yerima, M. B. (2025) · Wiley eBooks · doi:10.1002/9781394214945.ch13 · Cited by 2
Crespi, E., Ghiglione, B., Crivelli, X. B., Cundon, C. C., Figueroa-Espinosa, R. A., Penzotti, P., Nuske, E., Broglio, A., Ambros, L., Rumi, M. V., et al. (2025) · Revista Argentina de Microbiología · doi:10.1016/j.ram.2025.05.001 · Cited by 2
Hakimah, N., Satria, G. D., Pawestri, W., & Indarjulianto, S. (2019) · Jurnal Sain Veteriner · doi:10.22146/jsv.34466 · Cited by 2
Hu, X., Na, G., Sun, Y., Xing, Y., Chen, L., & Gai-ping, Z. (2023) · Food Additives & Contaminants Part A · doi:10.1080/19440049.2023.2266516 · Cited by 2
“It was found that CPZ is a potential risk for engendering adverse reactions, such as dermatological reactions, leukocytosis, obstructive and orthostatic hypotension, leukopenia and jaundice (Lekshmi et al. 2017).”
BackgroundUllah, B., Esa, M., Kamal, Z., Khan, K. A., & Shafique, M. W. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.4830805 · Cited by 2
Ullah, S., Zahra, Q., Arshad, M. A., Shah, A. A., Asghar, M. U., Arshad, M., & Fatima, M. (2026) · Indus journal of bioscience research. · doi:10.70749/ijbr.v4i2.2888 · Cited by 1
Liu, Z., Guo, L. J., Fei, L., Nian, R., Ni, S., Yang, S., & Gao, Y. (2026) · Animal Feed Science and Technology · doi:10.1016/j.anifeedsci.2026.116719 · Cited by 1
Emergence of Antimicrobial Resistance and Interaction Between Humans, Animals and Environment
(2021) · International Journal of Veterinary Science · doi:10.47278/book.vpph/2021.028 · Cited by 1
(2022) · Jordan Journal of Biological Sciences · doi:10.54319/jjbs/150302 · Cited by 1
Yushina, Y. K., Zaiko, E. V., Makhova, A., Султановна, Б. Д., & Nasyrov, N. (2023) · BIO Web of Conferences · doi:10.1051/bioconf/20236701014 · Cited by 1
Probiotics in Poultry Preharvest Food Safety: Historical Developments and Current Prospects
Perumalla, A. V. S., Wythe, L. A., & Ricke, S. C. (2023) · Springer eBooks · doi:10.1007/978-3-031-40512-9_7 · Cited by 1
Ma, T., & Guan, L. L. (2023) · Springer eBooks · doi:10.1007/978-3-031-40512-9_3 · Cited by 1
Antimicrobial Assay of Metal Ions Using Yeast and Its Relevance to Food Preservation
Cao, Z., Islam, M. S., Sisler, J. F., & Tam, K. C. (2024) · ACS Food Science & Technology · doi:10.1021/acsfoodscitech.4c00079 · Cited by 1
Owusu, M., Basnet, A., & Kilonzo‐Nthenge, A. (2024) · Frontiers in Sustainable Food Systems · doi:10.3389/fsufs.2024.1460350 · Cited by 1
Gadde, U. D., Oh, S., Lillehoj, H. S., & Lillehoj, E. P. (2021) · Scientific Reports · doi:10.1038/s41598-021-82285-2 · Cited by 1
RetractedGarhia, G., Mani, M., Kumar, D., & Upadhyay, A. K. (2020) · doi:10.21203/rs.3.rs-32058/v1 · Cited by 1
“Development of antimicrobial resistant (AMR) campylobacters has been linked to the indiscriminate use of antimicrobials in food animal production system (poultry and swine) for disease prevention and growth promotion (11, 12).”
BackgroundMorrison, B. J. (2019) · HARVEST (University of Saskatchewan) · Cited by 2
Na, G., Hu, X., Sun, Y., Tang, L., Xing, G., Xing, Y., & Zhang, G. (2020) · doi:10.21203/rs.3.rs-31729/v1
“It was found that CPZ is a potential risk for engendering adverse reactions, such as dermatological reactions, leukocytosis, obstructive and orthostatic hypotension, leukopenia and jaundice [10].”
BackgroundRivera-Díaz, J., Phillippi, H., Mbogo, N., Nawrocki, E. M., & Dudley, E. G. (2022) · American Journal of Undergraduate Research · doi:10.33697/ajur.2022.064
Rahat, S., Ahmad, K., & Ali, A. (2023) · Journal of the Hellenic Veterinary Medical Society · doi:10.12681/jhvms.27474
Dhital, R. (2022) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/94211
Shahi, M. K. (2022) · Chula Digiverse · doi:10.58837/chula.the.2022.369 · Cited by 1
Animales de compañía, elemento clave en la resistencia a los antibióticos
Aguilera, S. S. (2023) · Revista Científica del Sistema de Estudios de Postgrado de la Universidad de San Carlos de Guatemala · doi:10.36958/sep.v6i2.196
Niroli, R., Rathod, V., Talloli, N., Singh, D., Talikote, R., Hosmani, S., Rayudu, K., & Dawood, S. (2023) · International Journal of Biosciences (IJB) · doi:10.12692/ijb/23.2.234-239
Ethnoveterinary Medical Practices: An Alternative to Antibiotics in the Animal Health Sector
Abubakar, M., Manzoor, S., & Syed, Z. (2023) · doi:10.61748/cam.2023/007
Bairán, G., Torres, E., & Bravo, E. C. (2022) · RD-ICUAP · doi:10.32399/icuap.rdic.2448-5829.2022.24.990
Rotter, A. G., da Rosa, B. C. D. O., Fernandes, A. P. M., Simões, E. P., Pinto, A. N., Reuter, A. H., Glaser, L. P. D. S., & Fernandes, J. I. M. (2024) · Semina Ciências Agrárias · doi:10.5433/1679-0359.2024v45n5p1367
Microbiota do queijo Minas Frescal: diversidade bacteriana e resistência aos antimicrobianos
Macedo, A. C. L. D. P. (2023) · doi:10.34019/ufjf/te/2023/00020
Anticipating HIV Vaccines: A Cross-cultural Behavioral Economic Demand AnalysisPreprint
Tewogbola, P. O., Adekunle, O. F., Odaudu, D., & Oyewole, T. (2025) · medRxiv · doi:10.1101/2025.05.11.25327407
Radeef, A. H., Obed, A. F., Sahib, Z. H., Matrood, A. A., & Kadhim, Q. M. (2025) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_1003_24
Nilawati, Yulia, E., & Novia, R. (2025) · Jurnal Peternakan Lokal · doi:10.46918/peternakan.v7i2.2710
Multidrug-resistance in Diverse Escherichia coli Pathogroups Isolated from Fish and Shellfish
Prakasan, S., Stephen, J., Lekshmi, M., Nayak, B. B., & Kumar, S. H. (2025) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.19.4.32
Self-citationAshbaugh, H. R., Pomeroy, C. D., Baishya, M. L., Creppage, K. E., Bazaco, S. L., Johnson, M., Matsumoto, K., Bhattarai, U., Seliga, N., Graf, P. C. F., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22603229
Ashbaugh, H. R., Pomeroy, C. D., Baishya, M. L., Creppage, K. E., Bazaco, S. L., Johnson, M., Matsumoto, K., Bhattarai, U., Seliga, N., Graf, P. C. F., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22603244
Ashbaugh, H. R., Pomeroy, C. D., Baishya, M. L., Creppage, K. E., Bazaco, S. L., Johnson, M., Matsumoto, K., Bhattarai, U., Seliga, N., Graf, P. C. F., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22603238
Ashbaugh, H. R., Pomeroy, C. D., Baishya, M. L., Creppage, K. E., Bazaco, S. L., Johnson, M., Matsumoto, K., Bhattarai, U., Seliga, N., Graf, P. C. F., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22603232
Ashbaugh, H. R., Pomeroy, C. D., Baishya, M. L., Creppage, K. E., Bazaco, S. L., Johnson, M., Matsumoto, K., Bhattarai, U., Seliga, N., Graf, P. C. F., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22603235
Ashbaugh, H. R., Pomeroy, C. D., Baishya, M. L., Creppage, K. E., Bazaco, S. L., Johnson, M., Matsumoto, K., Bhattarai, U., Seliga, N., Graf, P. C. F., et al. (2023) · Figshare · doi:10.6084/m9.figshare.22603241
Coppola, N. (2024) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Abolarinwa, T. O., Ajose, D. J., Oluwarinde, B. O., Ewunkem, A. J., Montso, P. K., Engohang‐Ndong, J., Callaway, T. R., Fayemi, O. E., Aremu, A. O., & Ateba, C. N. (2026) · International Journal of Microbiology · doi:10.1155/ijm/6662085
“The AMR development in bacteria of animal origin is a risk to human health because of horizontal gene transfer via genetic mobile elements, conferring resistance to novel pathogenic organisms [68].”
Mabandza, B. D. B. (2024) · theses.fr (ABES) · doi:10.70675/9ae1dd65z81c2z4558z93e5zf2b97f4efecf
Sırıken, B., Öztürk, M. F., Kaydu, V., SEZENER, M. G., Keleş, E., & Erol, İ. (2026) · Microbial Drug Resistance · doi:10.1177/10766294261454147
“5,6 The increasing occurrence of clinically relevant MDR E. coli represents a serious threat to the sustained ef fi cacy of antibiotic therapies.”
Rahman, M. H., Zowalaty, M. E. E., Eze, E. C., Falgenhauer, L., Khan, M. F. R., Alam, J., Rahman, M. A., Saleh, A., Selim, H. M. R. M., Gomaa, F. A. M., et al. (2026) · Annals of Animal Science · doi:10.2478/aoas-2026-0003
“…(Silbergeld et al., 2008; Economou and Gousia, 2015; Robinson et al., 2016 a; de Mesquita Souza Saraiva et al., 2022), as these bacteria might spread from food to humans and lead to not well treatable infections (Marshall and Levy, 2011; Capita and Alonso-Calleja, 2013; Lekshmi et al., 2017).”
Abdelhady, A. Y., El-Safty, S. A., Hashim, M., Abdelaziz, M., Fathi, M. M., & hemida, M. A. (2026) · Veterinary and Animal Science · doi:10.1016/j.vas.2026.100832
Antibiotic Potency and Resistance: A Critical Review of Analytical and Microbiological Methodologies
Pethani, T. M., Suva, H., Patel, J., & Bharad, P. (2026) · Biomedical Chromatography · doi:10.1002/bmc.70523
Prerana, R., Dhanush, C. K., Lekshmi, M., & Kumar, S. H. (2025) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.20771379
Self-citationAhmed, M. J., Bhandari, P., Bhuiyan, M. I. H., Chalise, R., Sarker, S., Yousuf, M. S. B., Easin, M., Rahi, M. R. U., Chakrabarty, H., Paul, A., et al. (2026) · Veterinary Medicine International · doi:10.1155/vmi/3617712
“Animal foods are particularly associated with FBDs because of their high pathogen load, natural toxins, adulterants, and other contaminants [17, 18].”
Tuhamize, B., & Daniel, K. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1952715
“Resistant bacteria originating from livestock may be transmitted to humans through consumption of contaminated meat, direct occupational exposure during animal handling and slaughter, or environmental dissemination via animal waste and agriculture runoff (Lekshmi et al., 2017, Robinson et al., 2016).”
Metadata
- Authors
- Lekshmi, M., Ammini, P., Kumar, S., & Varela, M. F.
- Affiliations
- Central Institute of Fisheries Education (IN)
- CSIR-National Institute of Oceanography (NIO), Regional Centre, Dr. Salim Ali Road, Kochi 682018, India
- Eastern New Mexico University (US)
- Corresponding author
- Varela, Manuel F.
- Venue
- Microorganisms
- Publisher
- MDPI AG
- Published
- 2017-03-14
- Volume
- 5
- Issue
- 1
- Pages
- 11
- ISSN
- 2076-2607 (ISSN-L)
- PMC
- PMC5374388
- OpenAlex
- W2595170873
- Cited by
- 194
- References
- 122
- Citations by year
- 2026: 12 · 2025: 16 · 2024: 18 · 2023: 37 · 2022: 26 · 2021: 25 · 2020: 30 · 2019: 13 · 2018: 15 · 2017: 2
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Microorganisms (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- European Food Safety Authority
- National Institutes of Health
- Centers for Disease Control and Prevention
- National Institute of General Medical Sciences (P20GM103451)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Life Sciences › Agricultural and Biological Sciences › Food Science › Salmonella and Campylobacter epidemiology
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- antimicrobial resistance, food production, zoonotic pathogens, antibiotic growth promoters, foodborne pathogens, Campylobacter, Salmonella, Escherichia coli, Staphylococcus aureus, antibiotic use in livestock, human health risk, critical antimicrobials, trophic transfer
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
![Figure 1 Global antimicrobial use in food animals (a) Major users of antimicrobials in livestock in 2010; (b) Major users of antimicrobials in livestock in 2030 (projected) [65].](https://figures.cochat.ai/paper-figures/0cf0592b99b94604b99caca67c3146f9/the-food-production-environment-and-the-development-of-antimicrobial-resistance-figure-1.jpg)